期刊文献+

Leptin in hepatocellular carcinoma 被引量:7

Leptin in hepatocellular carcinoma
下载PDF
导出
摘要 The risk factors for hepatocellular carcinoma (HCC) development have been established,and include chronic hepatitis B and C,heavy alcohol consumption,and aflatoxins.In fact,5%-30% of patients with HCC still lack a readily identifiable risk factor.It has been reported that the majority of "cryptogenic" HCC may be attributed to nonalcoholic fatty liver disease,the hepatic presentation of the metabolic syndrome (MS).Obesity is associated with the development of the MS.Recently,adipose tissue has been considered as an endocrine organ because of its capacity to secrete a variety of cytokines,which are collectively known as the adipokines.Leptin,the product of the obese gene,is mainly produced by adipose tissue.Since leptin was first characterized in 1994,accumulated literature has demonstrated the involvement of this adipokine in several areas of human physiology.After binding to its receptor,leptin initiates a cascade of signaling events and subsequent cellular effects.In addition to being the regulatory mediator of energy homeostasis,several in vitro studies have demonstrated the fibrogenic role of leptin in the liver.Furthermore,the deregulated expression of leptin and its receptor have been demonstrated to be associated with a variety of metabolic disorders as well as human cancers.Most importantly,direct evidence supporting the inhibitory and/or activating role of leptin in the process of carcinogenesis and progression of human HCC has been accumulating rapidly.This review aims to provide important insights into the potential mechanisms of leptin in the development of HCC.Hopefully,further investigations will shed light on a new therapeutic target in HCC. The risk factors for hepatocellular carcinoma (HCC) development have been established,and include chronic hepatitis B and C,heavy alcohol consumption,and aflatoxins.In fact,5%-30% of patients with HCC still lack a readily identifiable risk factor.It has been reported that the majority of 'cryptogenic' HCC may be attributed to nonalcoholic fatty liver disease,the hepatic presentation of the metabolic syndrome (MS).Obesity is associated with the development of the MS.Recently,adipose tissue has been considered as an endocrine organ because of its capacity to secrete a variety of cytokines,which are collectively known as the adipokines.Leptin,the product of the obese gene,is mainly produced by adipose tissue.Since leptin was first characterized in 1994,accumulated literature has demonstrated the involvement of this adipokine in several areas of human physiology.After binding to its receptor,leptin initiates a cascade of signaling events and subsequent cellular effects.In addition to being the regulatory mediator of energy homeostasis,several in vitro studies have demonstrated the fibrogenic role of leptin in the liver.Furthermore,the deregulated expression of leptin and its receptor have been demonstrated to be associated with a variety of metabolic disorders as well as human cancers.Most importantly,direct evidence supporting the inhibitory and/or activating role of leptin in the process of carcinogenesis and progression of human HCC has been accumulating rapidly.This review aims to provide important insights into the potential mechanisms of leptin in the development of HCC.Hopefully,further investigations will shed light on a new therapeutic target in HCC.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第46期5801-5809,共9页 世界胃肠病学杂志(英文版)
基金 Supported by Kaohsiung Medical University Hospital Cancer Center through funding by the Department of Health,Taiwan,China NSC Grant 95-2314-B-037-046 from the National Science Council,Taiwan,China
关键词 ADIPOKINE HEPATOCELLULAR carcinoma LEPTIN Liver CIRRHOSIS METABOLIC syndrome Obesity STEATOHEPATITIS Adipokine Hepatocellular carcinoma Leptin Liver cirrhosis Metabolic syndrome Obesity Steatohepatitis
  • 相关文献

参考文献94

  • 1Xiu-JieWang,Shu-LanYuan,QingLu,Yan-RongLu,JieZhang,YanLiu,Wen-DongWang.Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma[J].World Journal of Gastroenterology,2004,10(17):2478-2481. 被引量:23
  • 2Huriye Balci,Kadriye Akgun-Dar,Nurperi Gazioglu,Aysegul Kapucu,Murat Bolayirli,Buge Oz.The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia[J]. Pituitary . 2009 (3)
  • 3Claudine Samanic,Gloria Gridley,Wong-Ho Chow,Jay Lubin,Robert N. Hoover,Joseph F. Fraumeni.Obesity and cancer risk among white and black United States veterans[J]. Cancer Causes and Control . 2004 (1)
  • 4Alicja Wolk,Gloria Gridley,Malin Svensson,Olof Nyrén,Joseph K. McLaughlin,Joseph F. Fraumeni,Hans-Olov Adami.A prospective study of obesity and cancer risk (Sweden)[J]. Cancer Causes and Control . 2001 (1)
  • 5Fung J,Lai CL,Yuen MF.Hepatitis B and C virus-related carcinogenesis. Clinical Microbiology and Infection . 2009
  • 6Thakur V,McMullen MR,Pritchard MT,Nagy LE.Regulation of macrophage activation in alcoholic liver disease. Journal of Gastroenterology and Hepatology . 2007
  • 7Albano E.Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine . 2008
  • 8Chen CH,Wang MH,Wang JH,Hung CH,Hu TH,Lee SC,Tung HD,Lee CM,Changchien CS,Chen PF,Hsu MC,Lu SN.Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan. American Journal of Tropical Medicine and Hygiene . 2007
  • 9Szkudelska K,Drzyma a H,Szkudelski T,Bukowska K,No-gowski L.Lack of the effect of mycotoxins-aflatoxin B1and ochratoxin A on some functions of rat adipocytes. Toxicology in Vitro . 2005
  • 10Abdel-Wahhab MA,Ahmed HH,Hagazi MM.Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts. Journal of Applied Toxicology . 2006

二级参考文献1

共引文献22

同被引文献64

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部